ENO2 and lung cancer: In addition, the assessment of blood circulating proteins like CEA, CYFRA 21-1 (serum cytokeratin 19 fragment), fibrinogen, C-reactive protein (CRP), and neuron-specific enolase (NSE), as markers of lung cancer progression, has been considered inconclusive [28].